Review compares strengths, limitations of available systems.
International registry begins to shed light on increased risk.
Molecular signatures could pinpoint indolent tumors.
First evidence-based U.S. guidelines reflect a more diverse population.
Multi-part research initiative explores how RNA-containing EVs fuel cancer growth.
Creating continuity to help pediatric patients thrive into adulthood.
1 / 5
Therapy may maintain healthy beta cell function.
REACH clinic expands its support for cancer patients and families.
Is addressing patient financial struggles the key to better outcomes?